[Upgrading of clinicoimmunological effectiveness of combined treatment in patients with chronic prostatitis].
Our investigation of immune and cytokine status in patients with chronic prostatitis shows that basic treatment neither normalizes nor improves life quality in patients with chronic prostatitis. The addition of azoximer injections to basic treatment of chronic prostatitis improves or normalizes the majority of abnormal parameters of immune and cytokine status except neutrophil phagocyte activity, IL-1beta concentration in the blood serum, IL-6 and IL-1beta concentration in prostatic gland secretion. Chronic prostatitis treatment with azoximer injections in combination with LRS has positive immunological and clinical effects.
O I
OI
Bratchikov
S G
SG
Shestakov
E A
EA
Shumakova
S V
SV
Makhov
D000328:Adult; D002908:Chronic Disease; D006801:Humans; D053583:Interleukin-1beta / Q000097:blood / Q000276:immunology*; D015850:Interleukin-6 / Q000097:blood / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000276:immunology*; D010587:Phagocytosis / Q000276:immunology*; D011472:Prostatitis / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D011788:Quality of Life
C508600:IL6 protein, human; D053583:Interleukin-1beta; D015850:Interleukin-6